MAY 2022LIFE SCIENCES REVIEW6Biotech, unlike most other industries, is witnessing a boom in these difficult times. As the global pandemic spreads, executives in many other industries are growing increasingly worried about their companies' prospects. However, the effort to understand and find preventive solutions to COVID-19 has drawn a lot of attention from the government, the media, and the general public, strengthening the impression that biotech acquisitions and partnerships are a smart investment.Companies from all across the world have redirected their efforts to quick testing kits, vaccinations, and repurposed pharmaceuticals since the outbreak of the pandemic began. They've also implemented trends like artificial intelligence (AI), automation, and data analytics to improve outcomes and efficiency. Aside from COVID-19, there is a lot of progress in areas like tissue engineering, gene editing, and sequencing.Companies are increasingly looking at new ways of collecting data with the help of machines as innovative biotech moves away from traditional data collection methods. This provides a bigger platform for healthcare facilities to collect and track data, as well as allowing physicians to identify new treatment options.At this juncture, to help organizations partner with the best vendors and catalyze their growth in biotech by utilizing the latest technologies, Life Science Review brings its biotechnology special edition, showcasing startups that are on top of their game in this arena. We hope the valuable insights from industry thought-leaders and the innovative solutions from leading startups featured in this edition will help you in your endeavors today, and tomorrow. We believe this edition will help you in evaluating and formalizing effective BioTech-powered strategies for your organization.EDITORIALThe Fascinating World ofBiotechnologyCopyright © 2022 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.Email:sales@lifesciencesreview.comeditor@lifesciencesreview.commarketing@lifesciencesreview.com MAY - 16 - 2022, Vol 03, Issue - 06 Published by ValleyMedia, Inc. (ISSN 2831-8331)To subscribe to Life Sciences ReviewVisit www.lifesciencesreview.com Editorial StaffAaron PierceCarolynn WaltersShirley FaithRussell ThomasVisualizersRonald DonovanDisclaimer: *Some of the Insights are based on our interviews with CIOs and CXOsJeremy WilliamsManaging Editoreditor@lifesciencesreview.comManaging EditorJeremy WilliamsSalesStephen Thomassales@lifesciencesreview.comVictor Cruz
< Page 5 | Page 7 >